scispace - formally typeset
T

Takehiko Yamanashi

Researcher at Tottori University

Publications -  32
Citations -  573

Takehiko Yamanashi is an academic researcher from Tottori University. The author has contributed to research in topics: Medicine & Delirium. The author has an hindex of 8, co-authored 18 publications receiving 376 citations. Previous affiliations of Takehiko Yamanashi include University of Iowa & Stanford University.

Papers
More filters
Journal ArticleDOI

Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor

TL;DR: These findings demonstrate that psychological "stress" is sensed by the innate immune system in the brain via the ATP/P2X7R-NLRP3 inflammasome cascade, and they identify novel therapeutic targets for the treatment of stress-related mood disorders and comorbid illnesses.
Journal ArticleDOI

Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses

TL;DR: It is demonstrated that Beta-hydroxybutyrate exerts antidepressant-like effects, possibly by inhibiting NLRP3-induced neuro-inflammation in the hippocampus, and that BHB may be a novel therapeutic candidate for the treatment of stress-related mood disorders.
Journal ArticleDOI

Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression

TL;DR: This is the first study to directly demonstrate the relationship between HPA axis dysregulation assessed with the DEX/CRH test and the index of insulin resistance estimated as HOMA-R in elderly MDD patients.
Journal ArticleDOI

Social cognition and prefrontal hemodynamic responses during a working memory task in schizophrenia

TL;DR: The results suggest that ToM integrity is closely related to lateral PFC functional abnormalities found in patients with schizophrenia and provide evidence to suggest that NIRS could be used to identify biomarkers of social cognition function in subjects with schizophrenia.